| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Aguirre Jarrad Mattieu serves as a Chief Medical Officer at LYEL. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $171K at current prices.
The biggest single holding is LYEL (~$171K) as Chief Medical Officer. The recent filings there lean toward selling, a net 422 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Medical Officer | Sell | 422 | $8.63 | $3,641.86 | -2.1% | - | - |